ECG Event Recorder Market Trends

  • Report ID: 3801
  • Published Date: Sep 25, 2025
  • Report Format: PDF, PPT

ECG Event Recorder Market - Growth Drivers and Challenges

Growth Drivers

  • Shift toward ambulatory and remote monitoring: The transition of the healthcare industry to value-based care is prompting wide adoption of remote patient monitoring (RPM). The products available in the ECG event recorder market, particularly wearable devices, allow patients to collect continuous rhythm data conveniently and affordably without requiring hospital stays, improving patient compliance. Besides, the emergence of telemedicine services, particularly after the pandemic, further accelerates the pace of this shift. Moreover, this movement toward decentralized cardiac care continues to fuel growth in this sector.
  • Growing awareness and early diagnosis campaigns: Governments and health organizations across the globe are increasingly participating in public awareness campaigns and cohorts to educate the maximum patient volume about the importance of early detection in managing severe heart conditions. Their efforts to promote regular screening, especially during Heart Month or World Heart Day, further push more people to consider adopting advanced tools from the market. As evidence, in 2024, the U.S. Preventive Services Task Force released new guidelines providing recognition to ECG abnormalities as the primary indicator of CVD events.
  • Integration of next-generation data analytics: The market is evolving rapidly through the increasing use of AI for seamless analysis of large rhythm data. As evidence, in May 2024, Philips demonstrated promising results from the retrospective study at the Heart Rhythm Annual Meeting in Boston, solidifying the efficiency of its AI-powered cardiac care pipeline. As per this dataset, the company’s MCOT device lowered hospital readmission rates by 5.2% compared to implantable loop recorders, while reducing the average 18-month cost of stroke events by USD 27,429. These figures yield greater efficiency out of AI-based recorders, making them more valuable to providers.

Demographic Trends in Key Medical Disciplines in the ECG Event Recorder Market

Overview of the Global CVD Durden (2022)

CVD Type

Number of Prevalent Cases

Number of Death

Cases

Prevalence

(per 100,000)

Deaths

(per 100,000)

DALYs

(per 100,000)

Rheumatic heart disease

46,358,651

386,947

575.5

4.5

162.5

Ischemic heart disease

315,390,626

9,239,181

3,610.2

108.8

2,275.9

Ischemic stroke

86,661,746

3,542,299

994.5

42.3

819.5

Intracerebral hemorrhage

20,509,587

3,428,876

237.9

39.4

923.8

Subarachnoid hemorrhage

9,281,913

344,872

107.2

4.0

120.7

Hypertensive heart disease

13,052,641

1,353,074

150.9

16.1

292.7

Non-rheumatic calcific aortic valve disease

13,551,699

146,199

156.6

1.8

26.8

Non-rheumatic degenerative mitral valve disease

15,592,046

37,843

177.9


0.5

 

11.1

Other non-rheumatic valve diseases

12,130

2,033

0.1

<0.1

0.6

Myocarditis

625,129

26,702

7.8

0.3

11.8

Alcoholic cardiomyopathy


554,214

 

62,661

6.3

0.7

24.6

Other cardiomyopathy

4,715,332

295,751

58.7

3.5

99.3

Pulmonary arterial hypertension

193,710

20,561

2.3

0.2

7.4

Atrial fibrillation and flutter

55,414,434

362,381


637.5

 

4.5

102.9

Lower extremity peripheral arterial disease

105,980,247

73,928

1,213.3

0.9

19.6

Endocarditis

438,374

82,402

5.4

1.0

25.8

Other cardiovascular and circulatory diseases

86,722,785

221,797

1,006.1

2.6

118.8

Source: NLM

Challenges

  • Pricing constraints and reimbursement limitations: Governments and insurance companies frequently impose price limits and strict reimbursement guidelines. This move favored local manufacturers, giving them a competitive edge over international companies. Dealing with various regulatory environments also becomes time-consuming and expensive due to their differing criteria. Thus, despite being a great favor to local manufacturers, these factors remain a hurdle for global companies seeking globalization.

Base Year

2025

Forecast Year

2026-2035

CAGR

8.1%

Base Year Market Size (2025)

USD 1.7 billion

Forecast Year Market Size (2035)

USD 3.4 billion

Regional Scope

  • North America (U.S. and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia-Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In 2026, the industry size of ECG event recorder is assessed at USD 1.8 billion.

ECG Event Recorder Market size was over USD 1.7 billion in 2025 and is estimated to reach USD 3.4 billion by the end of 2035, expanding at a CAGR of 8.1% during the forecast timeline, i.e., 2026-2035.

North America industry is predicted to account for the largest share of 39.3% by 2035, owing to a well-developed cardiac care infrastructure in the region.

The major players in the market are Koninklijke Philips N.V., WellDoc, Inc., Noom, Inc., Pear Therapeutics, Inc., Teladoc Health, Inc., Click Therapeutics, Inc., Ayogo Health Inc., Mindstrong Health, and others.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos